Genericaura Active Ingredient Solutions is a contract development and manufacturing organization (CDMO) specializing in active pharmaceutical ingredient (API) supply and custom synthesis.
Genericaura Active Ingredient Supplier is a contract development and manufacturing organisation (CDMO) specializing in active pharmaceutical ingredient (API) supply and custom synthesis.
The company is the new branding of Genericaura API third-party business. More than 2,000 women and men are developing, manufacturing, and supplying API and technological solutions for external customers and partners in 80 countries.
To do so, the company works with passion, pride, and rigour, recognising that its products are the key contributor to therapeutic solutions, helping millions of people live life to its full potential, every day, all over the world. Genericaura is the world’s best Active Pharmaceutical Ingredient Suppliers.
For innovative pharmaceutical companies, from start-ups to big pharma companies, generics pure players and through its catalogue of high-quality active ingredients and its contract development and manufacturing organisation, the company delivers expertise and customized solutions that contribute to the success of your business.
As a global leader, Genericaura Active Ingredient Solutions has been supporting customers for decades with innovative, efficient and safe solutions, high-quality products and premium customer service.
Contract development and manufacturing services for medical drugs
Genericaura Active Ingredient Solutions offers pharmaceutical drug developers in more than 80 countries with API and technological solutions, supporting partners from process development to regulatory submission.
Its expertise covers multiple therapeutic areas for human and animal health, including corticosteroids, hormones, viral vectors, multi-step chemistry, opiates, prostaglandins and high-active products, as well as plasmids, and oligosaccharides, peptides, oligosaccharides, biotechnologies and monoclonal antibodies (mAb).
Genericaura Active Ingredient Solutions partners with innovative companies ranging from start-ups to some of the biggest pharmaceutical players. Its catalogue of high-quality APIs and customised CDMO services delivers expertise and contributes to key therapeutic solutions that help millions of people.
The company has been supporting customers for decades with innovative, efficient and safe solutions, as well as high-quality products and customer service. It focuses on the continuous improvement of manufacturing processes to optimise output and meet client expectations.
Genericaura Active Ingredient Solutions’ synthesis API portfolio covers cardiovascular disease, metabolic disorders, analgesics and non-fluorinated glucocorticoids and derivatives (NSAID), as well as central nervous system (CNS) disorders and anaesthetics.
In the corticosteroids and hormones field, the company has more than 60 years of experience and is a fully integrated corticoid manufacturer.
While many pharmaceutical companies are located in the United States and England, most API manufacturers are overseas. Other than the U.S., the largest are located in Asia, particularly in India and China, according to the FDA.
More and more companies are outsourcing to cut costs on expensive equipment, employees, and infrastructure, according to Beroe, procurement alliance and supplier compliance, company. While this has helped their bottom line, there is continued concern about the quality of these APIs produced overseas.
Clinical supply and commercial manufacturing for the biotech industry
Genericaura Active Ingredient Solutions has been providing biotech customers with services ranging from clinical supply to commercial manufacturing since 1985. Using its dedicated biotech platform, the company has gained a significant track record, working on an average of more than 70 batches per year.
The company has 25 years of experience in the field of oligosaccharides. Genericaura Active Ingredient Solutions’ analytical expertise guarantees purity and quality, while its robust supply chain is widely recognised.
Fermentation technologies, nutraceuticals, vitamins and probiotics
Genericaura Active Ingredient Solutions offers large-volume fermentation services and has proven expertise in nutraceuticals, vitamins and probiotics.
The company meets clients’ specific demands with the highest standards.
It has long-standing expertise in organic chemistry with specific competencies in complex and long synthesis, as well as supports its customers’ projects from early phases through to validation campaigns.
APIs for human and animal health
Genericaura Active Ingredient Solutions is a world leader in the manufacturing of prostaglandins, with a strong historical background in process development and the scale-up of new chemical entities. Its portfolio includes 18 prostaglandin APIs.
The company’s production lines are multi-purpose, allowing quick and flexible developments and scale-ups, along with constant high quality. It also provides exhaustive regulatory support to its customers.
Genericaura Active Ingredient Solutions is the sole European vitamin B12 manufacturer, while its biotech API catalogue offers 14 APIs, including antibiotics and anti-tuberculosis.
Beyond the APIs, the company has developed a strong customer-oriented policy with a large range of possible specifications and customisations.
Opiates from poppy seeds to APIs
Genericaura Active Ingredient Solutions provides opiates in forms ranging from poppy seeds to APIs.
The company’s portfolio comprises 15 opiate APIs with applications in agronomic research, industrial and agricultural production, and distribution. It grows and harvests 10,000 ha of poppies each year.
Genericaura is the fastest growing and reputed Manufacturing, Trading & Export Company in Healthcare & pharmaceutical Industry for over a decade, based in Surat, Gujarat, India.
Our strengths include Chemical Synthesis, Formulation Development and Manufacturing, Clinical and Regulatory expertise, a robust global supply chain and strategic networks.
is one of the main pharmaceutical fare organizations. We have our presence in the worldwide market for the last 10 years due to our responsibility to give quality items and our excellent help for the advancement of our items.
Our manufacturing facility meets stringent GMP norms, laid down in the “Revised Schedule M” by the Drug Controller (General) India, Ministry of Health, and Government of India. With an unwavering commitment to quality,
Genericaura Quality Policy covers the entire gamut of our operations, from using the best raw materials to strict control at every stage of manufacturing and packaging.
Genericaura its India cost-base together with its broad aptitude and development stages to offer focused, astonishing, custom assembling organizations to a worldwide customer base. Highlights of Our Contract Manufacturing Services Best units adhere to WHO-GMP conclusions. A totally computerized system for manufacturing. Capacities to make estimation outlines in sterile and general, covering each and every accommodating part including small and expansive volume parenteral. Dedicated generation workplaces for Beta-Lactam, Cephalosporin things. Qualified and experienced speciate organization in all features of Pharma Contract Manufacturing like QC, QA, and Product Development.
We offer the product Agomelatine Manufacturer, 138112-76-2 from our manufacturer/supplier/principals for your Research and Development / Evaluation or Commercial requirements, based on the product’s availability from our network. We can also offer Agomelatine, 138112-76-2 intermediates with the supportive technical package required for evaluation.
We respect our customer’s requirements of strict regulatory compliance and specification needs by offering the API – Active Pharmaceutical Ingredients and intermediates transparently while offering easy access to manufacturer/supplier/principals with affordable and high-quality raw materials.
If you are looking for the API –Active Pharmaceutical Ingredients Agomelatine, 138112-76-2 manufacturer supplier who is reliable and meets your required quality standard requirements in the first place, you are in the right place!
Genericaura Pharmaceuticals Limited” Hyderabad, India is the world’s largest manufacturer of Tadalafil API. For the last 20 years, Genericaura is manufacturing Tadalafil & other APIs. Genericaura has 5 cGMP compliance factories with high volume equipment to manufacture RPL Products Details Tadalafil in large bulk quantities. Genericaura is well established and reputed Tadalafil API Manufacturer, Supplier & Exporter to all major global markets including highly regulated North America, Europe, Japan, Korea, & also to South America, Asia & Middle East. Genericaura manufactures Tadalafil in USP, EP, and IP pharmacopeia. Genericaura facilities are approved by reputed regulatory authorities like USFDA, Japan PMDA, Korea-MFDS, CDSCO-India, and Mexico-Cofepris, and also have approved CEP for several API’s. Genericaura facilities have obtained certifications of WHO-GMP & Europe-WC (Written Confirmation). Genericaura has filed Tadalafil CEP no is 2016-317.